News

Use of Johnson & Johnson vaccine strictly restricted by FDA – New York Daily News


The Meals and Drug Administration strictly restricted use of the Johnson & Johnson COVID vaccine on Thursday.

The Johnson & Johnson vaccine was tied to 60 circumstances of a uncommon blood clotting illness referred to as thrombosis with thrombocytopenia syndrome. 9 individuals have died from TTS brought on by the vaccine, in response to the FDA.

Now, the Johnson & Johnson vaccine is just beneficial for individuals who can’t entry one other vaccine or individuals who have circumstances that make the mRNA vaccines developed by Pfizer and Moderna extra harmful.

The FDA additionally mentioned that anybody who particularly calls for the Johnson & Johnson vaccine and refuses the opposite pictures can obtain the J&J jab.

“Our action reflects our updated analysis of the risk of TTS following administration of this vaccine and limits the use of the vaccine to certain individuals,” mentioned Dr. Peter Marks, director of the FDA’s Heart for Biologics Analysis and Analysis.

The one-shot Johnson & Johnson vaccine is marginally much less efficient at stopping COVID an infection and extreme sickness than the Pfizer and Moderna vaccines. Nonetheless, U.S. public well being officers careworn in early 2021 that “the best vaccine is the one that you can get the soonest.”

In April 2021, use of the Johnson & Johnson vaccine was paused for about a week earlier than injections resumed. In December, a Facilities for Illness Management panel recommended the Pfizer and Moderna vaccines as superior to the Johnson & Johnson shot.

Solely about 18 million doses of the Johnson & Johnson vaccine have been administered, in comparison with 340 million doses of the Pfizer vaccine and 217 million doses of the Moderna vaccine, in response to CDC data. Individuals who received a Johnson & Johnson shot months in the past are usually not vulnerable to growing TTS. The clots develop between one and three weeks after vaccination.



Source link

Leave a Reply

Your email address will not be published.

close